{"organizations": [], "uuid": "4325e71669e7e329f120cd39044722b265eccced", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180521.html", "section_title": "Archive News &amp; Video for Monday, 21 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-lannett-receives-fda-approval-for/brief-lannett-receives-fda-approval-for-dronabinol-capsules-idUSASC0A2ZW", "country": "US", "domain_rank": 408, "title": "BRIEF-Lannett Receives FDA Approval For Dronabinol Capsules", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.983, "site_type": "news", "published": "2018-05-21T18:59:00.000+03:00", "replies_count": 0, "uuid": "4325e71669e7e329f120cd39044722b265eccced"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-lannett-receives-fda-approval-for/brief-lannett-receives-fda-approval-for-dronabinol-capsules-idUSASC0A2ZW", "ord_in_thread": 0, "title": "BRIEF-Lannett Receives FDA Approval For Dronabinol Capsules", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "fda approval for dronabinol capsules", "sentiment": "negative"}, {"name": "reuters) - lannett company inc", "sentiment": "neutral"}, {"name": "usp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21 (Reuters) - Lannett Company Inc:\n* LANNETT RECEIVES FDA APPROVAL FOR DRONABINOL CAPSULES * LANNETT COMPANY INC - RECEIVED APPROVAL OF ABBREVIATED NEW DRUG APPLICATION FOR DRONABINOL CAPSULES USP, 2.5 MG, 5 MG AND 10 MG\n* LANNETT - EXPECT TO COMMENCE MARKETING SEVERAL PRODUCTS INCLUDING DRONABINOL CAPSULES OVER COURSE OF YEAR\n* LANNETT COMPANY INC - FDA APPROVAL FOR DRONABINOL CAPSULES,THERAPEUTIC EQUIVALENT TO REFERENCE LISTED DRUG, MARINOL CAPSULES OF ABBVIE Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-21T18:59:00.000+03:00", "crawled": "2018-05-22T19:28:06.004+03:00", "highlightTitle": ""}